Laurus Labs Ltd. · LAURUSLABS
Every Laurus Labs Ltd. result whose ten-session window has closed, judged against the last read made before it. Sector index NIFTY PHARMA. Open a result for the full account: the read, the sessions after, the reported figures, and every morning's read that led up to it. The company's own page →
25results judged
3read right
2read wrong
1flat / no call
19unread
56%beat the market
+2.5%avg vs market, 10d
6.9%avg move, T+1
How the reads on it fared
| Read | Judged | Right | Wrong | Flat | Hit rate | Avg vs mkt | |
|---|---|---|---|---|---|---|---|
| strong | 6 | 3 | 2 | 1 | 60% | +3.9% | |
| unread | 19 | 0 | 0 | 0 | — | +2.1% |
A company that is often read strong and often proves it is one the model understands; one that is read strong and keeps lagging is where the model is wrong about a name, and this table is where that shows first.
Reading the rows
- T+1
- the share's move on the first session after the result, from the close before it
- T+10
- the move over ten sessions, same base
- vs market
- T+10 less NIFTY 50's move over the same ten sessions — the number every read is judged on
- Run-up
- the share's move in the thirty sessions before the result
- Result
- reported profit growth against the company's own last four quarters: good, in line, bad
Each result
25 judged · newest first · open one| Result | Read | Outcome | T+1 | T+10 | vs market | Run-up | Result | Why | |
|---|---|---|---|---|---|---|---|---|---|
| 24 Jul Q1FY27 | strong | right | +9.8% | +15.8% | +12.4% | +15% | no figures |
|
› |
| 30 Apr Q4FY26 | strong | right | +5.7% | +20.6% | +22.0% | +14% | no figures |
|
› |
| 23 Jan Q3FY26 | strong | wrong | -1.7% | -4.9% | -8.5% | -0% | no figures |
|
› |
| 23 Oct Q2FY26 | strong | right | +0.6% | +7.1% | +8.4% | +4% | no figures |
|
› |
| 25 Jul Q1FY26 | strong | neutral | +8.6% | -0.7% | +0.3% | +26% | no figures |
|
› |
| 24 Apr Q4FY25 | strong | wrong | -2.9% | -8.1% | -10.9% | +11% | no figures |
|
› |
| 24 Jan Q3FY25 | — | unread | -15.2% | +3.9% | +2.7% | +7% | no figures |
|
› |
| 24 Oct Q2FY25 | — | unread | +10.0% | +11.6% | +12.7% | -12% | no figures |
|
› |
| 25 Jul Q1FY25 | — | unread | +4.0% | -1.7% | -1.6% | -2% | no figures |
|
› |
| 25 Apr Q4FY24 | — | unread | +4.2% | +1.7% | +3.7% | +1% | no figures |
|
› |
| 24 Jan Q3FY24 | — | unread | -6.7% | -2.1% | -3.6% | +3% | no figures |
|
› |
| 20 Oct Q2FY24 | — | unread | -11.0% | -7.1% | -6.5% | -2% | no figures |
|
› |
| 27 Jul Q1FY24 | — | unread | +2.4% | +12.9% | +14.1% | -4% | no figures |
|
› |
| 27 Apr Q4FY23 | — | unread | +6.7% | +6.6% | +3.9% | -5% | no figures |
|
› |
| 30 Jan Q3FY23 | — | unread | -3.4% | -2.5% | -3.4% | -13% | no figures |
|
› |
| 21 Oct Q2FY23 | — | unread | -6.9% | -7.3% | -10.6% | -13% | no figures |
|
› |
| 27 Jul Q1FY23 | — | unread | +1.7% | +10.2% | +3.8% | +0% | no figures |
|
› |
| 28 Apr Q4FY22 | — | unread | +3.8% | -5.1% | +3.0% | -1% | no figures |
|
› |
| 27 Jan Q3FY22 | — | unread | +8.2% | +18.3% | +16.8% | -10% | no figures |
|
› |
| 28 Oct Q2FY22 | — | unread | -7.9% | -8.8% | -10.2% | -19% | no figures |
|
› |
| 29 Jul Q1FY22 | — | unread | +8.1% | +16.8% | +12.1% | -2% | no figures |
|
› |
| 29 Apr Q4FY21 | — | unread | +4.2% | +3.5% | +3.3% | +26% | no figures |
|
› |
| 28 Jan Q3FY21 | — | unread | -2.3% | +4.8% | -4.9% | +6% | no figures |
|
› |
| 29 Oct Q2FY21 | — | unread | -8.8% | -13.9% | -22.9% | +18% | no figures |
|
› |
| 30 Jul Q1FY21 | — | unread | +27.4% | +27.8% | +27.1% | +55% | no figures |
|
› |